VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KNSA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KNSAKiniksa Pharmaceuticals, Ltd.
$67.29$5.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKNSAQuarterly Financials

Kiniksa Pharmaceuticals, Ltd. (KNSA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kiniksa Pharmaceuticals, Ltd. (KNSA) quarterly income statement — complete revenue, gross profit & net income history

KNSA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue214.27M202.13M180.85M156.8M137.78M122.54M112.21M108.63M79.86M83.39M67.05M71.47M48.34M61.88M99.14M26.97M32.19M18.75M12.1M7.7M
Revenue Growth %55.51%64.95%61.17%44.34%72.54%46.93%67.37%51.99%65.18%34.76%-32.37%164.99%50.19%230.14%719.64%250.1%----
Cost of Goods Sold091.1M83.59M71.02M61.66M66.17M49.42M42.45M31.54M26.76M27.4M22.75M16.45M14.23M12.51M9.8M13.57M3.87M3.84M3.48M
COGS % of Revenue-45.07%46.22%45.29%44.75%54%44.04%39.08%39.49%32.09%40.86%31.82%34.03%23%12.62%36.32%42.15%20.63%31.77%45.2%
Gross Profit0111.03M97.26M85.76M76.13M56.36M62.8M66.18M48.32M56.64M39.65M48.73M31.89M47.65M86.63M17.18M18.62M14.88M8.25M4.22M
Gross Margin %-54.93%53.78%54.7%55.25%46%55.96%60.92%60.51%67.91%59.14%68.18%65.97%77%87.38%63.68%57.85%79.37%68.23%54.8%
Gross Profit Growth %-100%96.99%54.88%29.6%57.55%-0.48%58.39%35.81%51.52%18.85%-54.23%183.71%71.25%220.29%949.63%306.8%2208.95%---
Operating Expenses185M91.26M73.24M65.62M62.85M75.66M72.46M66.29M64.86M56.55M50.58M51.88M43.09M41.6M40.21M36.54M41.94M51.01M38.92M44.78M
OpEx % of Revenue86.34%45.15%40.5%41.85%45.62%61.75%64.57%61.03%81.22%67.82%75.43%72.59%89.12%67.23%40.56%135.48%130.3%272.12%321.79%581.22%
Selling, General & Admin61.15M56.77M49.1M46.86M43.53M40.53M46.4M42.4M38.68M36.74M33.76M28.41M28.2M27.21M23.91M23.09M21.48M22.74M20.06M21.25M
SG&A % of Revenue28.54%28.09%27.15%29.89%31.59%33.08%41.35%39.03%48.44%44.05%50.36%39.74%58.34%43.98%24.11%85.63%66.74%121.32%165.83%275.8%
Research & Development27.48M34.64M24.14M18.75M19.32M35.13M26.06M23.9M26.18M19.82M16.81M23.48M14.88M14.39M16.31M13.45M20.46M27.43M18.86M23.53M
R&D % of Revenue12.82%17.14%13.35%11.96%14.03%28.67%23.22%22%32.78%23.76%25.08%32.84%30.79%23.25%16.45%49.86%63.56%146.35%155.96%305.41%
Other Operating Expenses1000K0000000000000000835K00
Operating Income29.27M19.77M24.02M20.16M13.27M-19.3M-9.66M-117K-16.54M81K-10.93M-3.15M-11.2M6.05M46.41M-19.37M-23.32M-36.13M-30.67M-40.55M
Operating Margin %13.66%9.78%13.28%12.86%9.63%-15.75%-8.61%-0.11%-20.71%0.1%-16.3%-4.41%-23.16%9.77%46.82%-71.81%-72.44%-192.75%-253.55%-526.41%
Operating Income Growth %120.52%202.43%348.72%17330.77%180.23%-23925.93%11.61%96.29%-47.75%-98.66%-123.54%83.72%51.99%116.74%251.35%52.24%52.68%31.7%29.04%-27.29%
EBITDA29.27M20.23M24.41M20.52M13.62M-18.9M-9.26M313K-16.08M317K-9.93M-2.09M-10.07M7.13M47.36M-18.27M-22.23M-35.46M-29.59M-39.54M
EBITDA Margin %13.66%10.01%13.49%13.09%9.88%-15.42%-8.25%0.29%-20.13%0.38%-14.81%-2.93%-20.82%11.52%47.78%-67.74%-69.05%-189.19%-244.66%-513.23%
EBITDA Growth %114.93%207.07%363.58%6455.27%184.7%-6061.83%6.74%114.95%-59.71%-95.55%-120.96%88.55%54.71%120.1%260.05%53.79%54.08%32.23%30.48%-26.46%
D&A (Non-Cash Add-back)0467K384K358K345K400K399K430K466K236K999K1.06M1.13M1.08M949K1.1M1.09M668K1.07M1.02M
EBIT023.27M27.16M20.16M13.27M-16.98M-9.66M-117K-16.54M2.45M-8.5M-1.24M-9.36M6.84M46.73M-19.27M-23.29M-36.13M-30.66M-40.55M
Net Interest Income02.72M02.72M00000537K2.43M1.92M3.66M794K322K103K34K77K5K6K
Interest Income02.72M02.72M000002.37M2.43M1.92M3.66M794K322K103K34K77K5K6K
Interest Expense0000000001.83M0000000000
Other Income/Expense3.41M3.5M3.14M2.72M2.29M2.32M2.46M2.42M2.27M2.37M2.43M1.92M1.83M794K322K103K34K77K5K6K
Pretax Income32.68M23.27M27.16M22.88M15.56M-16.98M-7.2M2.3M-14.28M2.45M-8.5M-1.24M-9.36M6.84M46.73M-19.27M-23.29M-36.05M-30.66M-40.55M
Pretax Margin %15.25%11.51%15.02%14.59%11.3%-13.86%-6.42%2.12%-17.88%2.94%-12.68%-1.73%-19.37%11.05%47.14%-71.43%-72.34%-192.34%-253.51%-526.34%
Income Tax-10.09M9.07M8.72M5.04M7.03M-8.09M5.49M6.21M3.43M-22.79M5.36M-16.21M2.91M2.38M-177.36M716K1.93M279K-118K1.01M
Effective Tax Rate %-30.87%38.98%32.12%22.05%45.14%47.65%-76.27%269.62%-24.01%-930.08%-63.02%1308.39%-31.03%34.79%-379.5%-3.72%-8.27%-0.77%0.38%-2.5%
Net Income22.59M14.2M18.43M17.83M8.54M-8.89M-12.69M-3.91M-17.7M25.24M-13.86M14.97M-12.27M4.46M224.09M-19.98M-25.21M-36.33M-30.54M-41.56M
Net Margin %10.54%7.02%10.19%11.37%6.2%-7.25%-11.31%-3.6%-22.17%30.26%-20.66%20.95%-25.38%7.21%226.05%-74.08%-78.32%-193.83%-252.53%-539.5%
Net Income Growth %164.57%259.75%245.24%556.29%148.23%-135.22%8.39%-126.1%-44.29%465.73%-106.18%174.93%51.33%112.28%833.67%51.93%49.05%32.29%30.32%-10.93%
Net Income (Continuing)22.59M14.2M18.43M17.83M8.54M-8.89M-12.69M-3.91M-17.7M25.24M-13.86M14.97M-12.27M4.46M224.09M-19.98M-25.21M-36.33M-30.54M-41.56M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.270.180.230.230.11-0.12-0.18-0.06-0.250.35-0.200.21-0.180.063.18-0.29-0.36-0.53-0.44-0.61
EPS Growth %145.45%250%227.78%518.18%144%-134.29%10%-126.19%-38.89%460%-106.29%172.41%50%111.79%822.73%52.46%50%32.91%33.33%6.15%
EPS (Basic)0.300.190.250.240.12-0.12-0.18-0.06-0.250.36-0.200.21-0.180.063.23-0.29-0.36-0.53-0.44-0.61
Diluted Shares Outstanding82.41M78.98M78.03M77.94M76.15M72.32M71.73M71M70.63M72.66M70.19M71.63M69.75M71.37M70.55M69.29M69.14M68.97M68.66M68.4M
Basic Shares Outstanding76.52M74.2M73.61M73.44M72.65M72.32M71.73M71M70.63M70.37M70.19M69.92M69.75M69.61M69.45M68.9M69.14M68.97M68.66M68.14M
Dividend Payout Ratio--------------------